Jeffrey D Milbrandt
Gründer bei Disarm Therapeutics, Inc.
Profil
Jeffrey D Milbrandt is the founder of PierianDx, Inc. Dr. Milbrandt is also the founder of Disarm Therapeutics, Inc.
Aktive Positionen von Jeffrey D Milbrandt
| Unternehmen | Position | Beginn |
|---|---|---|
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Gründer | - |
Ehemalige bekannte Positionen von Jeffrey D Milbrandt
| Unternehmen | Position | Ende |
|---|---|---|
PierianDx, Inc.
 PierianDx, Inc. Information Technology ServicesTechnology Services PierianDx, Inc. provides genomic software and services. It develops a platform to manage, analyze, and interpret complex genomic tests for clinical laboratories across the United States. The firm?s genomics software platform, Clinical Genomicist Workstation (CGW), provides data-driven workflow for health systems, academic medical centers, and commercial labs to improve patient outcomes through genomic analysis, interpretation and reporting. The company was founded by Jeffrey D. Milbrandt, Karen Seibert, John D. Pfeifer, Herbert W. Virgin, and Rakesh Nagarajan in 2014 and is headquartered in St. Louis, MO. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
PierianDx, Inc.
PierianDx, Inc. Information Technology ServicesTechnology Services PierianDx, Inc. provides genomic software and services. It develops a platform to manage, analyze, and interpret complex genomic tests for clinical laboratories across the United States. The firm?s genomics software platform, Clinical Genomicist Workstation (CGW), provides data-driven workflow for health systems, academic medical centers, and commercial labs to improve patient outcomes through genomic analysis, interpretation and reporting. The company was founded by Jeffrey D. Milbrandt, Karen Seibert, John D. Pfeifer, Herbert W. Virgin, and Rakesh Nagarajan in 2014 and is headquartered in St. Louis, MO. | Technology Services |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
